IMT EXCLUSIVE - S.H.O.W
SEX HORMONE OPTIMIZATION FOR WOMEN
WHAT MAKES THE S.H.O.W PROGRAM BETTER
THAN OTHER HRT PROGRAMS FOR WOMEN?
Most female Hormone Replacement Therapy programs focus on a single hormone that is low or out of range instead of trying to rebalance them.
THERE ARE 3 MAIN SEX HORMONES IN WOMEN
Estrogen, Progesterone and Testosterone work in a biorhythmic cycle and fluctuate on a 28-day cycle. During the days leading up to menstrual bleeding estrogen is on the rise and comes to a peak. Progesterone then increases as estrogen falls and stimulates the uterus and this triggers menstrual bleeding. Testosterone levels are generally known to stay roughly the same.
When women supplement just one of the 3 major sex hormones, like estrogen, it suppresses the other 2 progesterone and testosterone. So you are fixing one problem and creating another. This effect is becoming to be known as estrogen dominance. Most women tend to complain of the same symptoms they have before menstrual bleeding. Having estrogen dominance can also be problematic for long term health and increase the risk of disease.
Most of the time the ratios of your core sex hormones are more important than the total amount in your body, since each hormone signals each other through the negative feedback loop. If these 3 main hormones become unbalanced and do not work in unison it can cause terrible pre and post-menopause symptoms. IMT strides to balance all 3 of these hormones and perfect the ratios between them. We attain this natural balance by providing a formulation that utilizes small amounts of these core sex hormones to get a synergistic effect. This will allow you the benefits of optimal hormone levels without the unwanted side effects of one of these hormones dominating the rest.
The benefits of a program like ours was recently substantiated with the following peer-reviewed clinical results of a study performed in 2011.
Percutaneous absorption of 17β-estradiol, as well as the absorption of progesterone, was associated with relief of climacteric symptoms. The cyclical transdermal delivery of combined bio-identical hormones may be advantageous because it mimics the secretory profiles of 17β-estradiol and progesterone in normally cyclic women over a 28-day period. Larger studies are needed to determine the long-term effects of our therapy.
Efficacy of biorhythmic transdermal combined hormone treatment in relieving climacteric symptoms: a pilot study